Akero Therapeutics Inc
(FRA:0K4)
€
20.12
-0.32 (-1.57%)
Market Cap: 1.50 Bil
Enterprise Value: 688.25 Mil
PE Ratio: 0
PB Ratio: 1.90
GF Score: 21/100 Akero Therapeutics Inc (FRA:0K4) Transcripts
- Akero Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Akero Therapeutics Inc Phase 2b SYMMETRY Data Presentation TranscriptOct 10, 2023
- Akero Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Akero Therapeutics Inc Phase 2b SYMMETRY Cohort D Data Presentation TranscriptJun 05, 2023
- Akero Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Akero Therapeutics Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 17, 2022
- Akero Therapeutics Inc Phase 2B HARMONY Trial Data Presentation TranscriptSep 13, 2022
- Akero Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2022
- Akero Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Akero Therapeutics Inc at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Akero Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- 1